 | Up a level |
Jump to: 2016
Number of items: 1.
2016
Fischer, M., Wulff, B., Baruchel, S., Berlanga, P., Trahair, T., Mechinaud, F., Schulte, J., Modak, S., Merks, J. H., Zwaan, C. M., Marshall, L. V., Casanova, M., Branle, F., Malet, I., Emeremni, A. C. and Geoerger, B. (2016). Phase 1 study of ceritinib in pediatric patients with malignancies harboring activated anaplastic lymphoma kinase (ALK): Safety, pharmacokinetics and efficacy results from the fed population. Eur. J. Cancer, 69. S. S49 - 2. OXFORD: ELSEVIER SCI LTD. ISSN 1879-0852